Cartesian Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -428.9% | -448.0% |
| FY2017 | — | -30,813.5% | -31,556.0% |
| FY2018 | — | -7,200.7% | -7,235.4% |
| FY2019 | — | -785.6% | -829.0% |
| FY2020 | — | -342.4% | -415.0% |
| FY2021 | — | -5.4% | -30.2% |
| FY2022 | — | 13.1% | 31.9% |
| FY2023 | — | -332.3% | -844.9% |
| FY2024 | — | -112.8% | -199.0% |
| FY2025 | — | -5,127.1% | -4,658.6% |